Fidia Balance Sheet Health

Financial Health criteria checks 3/6

Fidia has a total shareholder equity of €4.6M and total debt of €1.0M, which brings its debt-to-equity ratio to 22.3%. Its total assets and total liabilities are €30.7M and €26.1M respectively.

Key information

22.3%

Debt to equity ratio

€1.02m

Debt

Interest coverage ration/a
Cash€2.13m
Equity€4.58m
Total liabilities€26.10m
Total assets€30.69m

Recent financial health updates

Recent updates

Investors Give Fidia S.p.A. (BIT:FDA) Shares A 34% Hiding

Oct 18
Investors Give Fidia S.p.A. (BIT:FDA) Shares A 34% Hiding

It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks

Aug 29
It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks

Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce

Jun 20
Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce

Estimating The Fair Value Of Fidia S.p.A. (BIT:FDA)

May 28
Estimating The Fair Value Of Fidia S.p.A. (BIT:FDA)

Risks Still Elevated At These Prices As Fidia S.p.A. (BIT:FDA) Shares Dive 31%

Feb 13
Risks Still Elevated At These Prices As Fidia S.p.A. (BIT:FDA) Shares Dive 31%

Is Fidia (BIT:FDA) A Risky Investment?

Dec 23
Is Fidia (BIT:FDA) A Risky Investment?

Fidia S.p.A.'s (BIT:FDA) Business Is Trailing The Industry But Its Shares Aren't

Oct 04
Fidia S.p.A.'s (BIT:FDA) Business Is Trailing The Industry But Its Shares Aren't

Financial Position Analysis

Short Term Liabilities: FDA's short term assets (€20.6M) do not cover its short term liabilities (€20.7M).

Long Term Liabilities: FDA's short term assets (€20.6M) exceed its long term liabilities (€5.4M).


Debt to Equity History and Analysis

Debt Level: FDA has more cash than its total debt.

Reducing Debt: FDA's debt to equity ratio has reduced from 153.2% to 22.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FDA has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: FDA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.1% each year


Discover healthy companies